Investigational New Drug (IND) Update

In this first IND update from CRISPR Medicine News, we look at three pre-clinical-stage CRISPR-engineered cell therapies that are under development for the treatment of sickle cell disease (SCD), beta-thalassemia, or acute lymphoblastic leukaemia (ALL).

Career CRISPR Medicine

• Senior Scientist in Regenerative Medicine | LEO Pharma - Denmark
• Freelancer | CRISPR Medicine News - Any place

Thank you for now - more great reads are on the way!

And if you have questions or suggestions, you can reach out to us directly at editor@crisprmedicinenews.com. We love hearing from readers!

Happy Reading!

Karen

p.s. You can follow CRISPR Medicine News on Twitter and LinkedIn. If someone forwarded this email to you, you can sign up for our newsletter yourself here.